OMC
PACB icon

Old Mission Capital’s Pacific Biosciences PACB Stock Holding History

Old Mission Capital’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-12,831
Closed -$15.1K – 1250
2025
Q1 		$15.1K Buy
+12,831
New +$19.7K ﹤0.01% 904
2021
Q3 		– Sell
-32,966
Closed -$1.15M – 1190
2021
Q2 		$1.15M Buy
+32,966
New +$959K 0.04% 392

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Old Mission Capital's PACB Position: Q2 2025 in Review

Old Mission Capital sold out of Pacific Biosciences (PACB) in Q2 2025, closing a stake of 12,831 shares — an estimated $15.1K sold.

Old Mission Capital first reported a position in PACB in Q2 2021 and held it in 2 quarters. The position peaked at $1.15M in Q2 2021. 207 funds tracked by Wall St. Rank hold PACB as of Q2 2025.

  • Old Mission Capital reported no remaining Pacific Biosciences position as of Q2 2025 after selling out during the quarter.
  • Old Mission Capital sold 12,831 Pacific Biosciences shares in Q2 2025, an estimated $15.1K.
  • Old Mission Capital first reported a position in Pacific Biosciences in Q2 2021 and held it in 2 quarters.
  • Old Mission Capital's Pacific Biosciences position peaked at $1.15M in Q2 2021.
  • 207 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2025.

Based on Old Mission Capital's 13F filing for Q2 2025, filed 14 Aug 2025.